Market & Competitive Analysis

Two Isolated Silos. NeuroFlo Connects Them.

The market is fragmented between front-end scribes and back-end coders — and the gap between them is exactly where revenue disappears.

The global AI medical coding market is growing fast, but it's currently fragmented on two isolated fronts. On one side, companies build ambient AI scribes to help doctors write notes faster. On the other, autonomous coding companies build backend AI to help hospitals read those notes. Both approaches are fundamentally flawed because they treat documentation and billing as two separate silos — if a surgeon writes a clinically vague note on the front end and forgets key details, the world's most advanced AI coder on the back end still cannot legally bill for the missing parts. The hospital still loses the revenue. NeuroFlo collapses the space between the operating table and the revenue cycle into a single, continuous intelligence loop — we don't passively decode whatever the surgeon happens to write, we actively partner with them in real time at the point of care.

Where Everyone Else Falls Short

Front-End Clinical Scribes

Nuance DAX, Abridge

They are purely passive; they transcribe what they hear without any knowledge of what belongs in a compliant, billable note.

Back-End Autonomous Coders

Fathom Health, CodaMetrix

They suffer from garbage in, garbage out — if an operative report is missing critical details, downstream AI will perfectly code an incomplete note.

Legacy EHR Analytics

Epic / Cerner native dashboards

About 80% of actual surgical nuance remains trapped in unstructured text that these dashboards were never built to read.

Market Size

Medical Coding Market

$20.8B → $30.4B

2026 to 2030, at a 10% CAGR

Source: The Business Research Company, 2026

AI in Medical Coding

$3.56B → $6B

2026 to 2030, at a 14% CAGR

Source: The Business Research Company, 2026

Enterprise Interoperability & Federal Contracting Readiness

Native SMART on FHIR Integration

NeuroFlo operates natively as a SMART on FHIR (Substitutable Medical Applications and Reusable Technologies on Fast Healthcare Interoperability Resources) application, integrating directly within EHR environments like Cerner and Epic. By launching inside the physician's existing workspace and exporting finalized notes directly back into the patient chart, NeuroFlo avoids heavy data liabilities and unnecessary ingestion of personally identifiable information, while eliminating multi-month IT integration delays.

Government Contracting & Defense Tech Capabilities

NeuroFlo is registered in SAM.gov (System for Award Management) as an Air Force veteran-owned healthcare technology enterprise, engineered to facilitate direct public-sector contracting, medical research, and defense health deployments across Department of Defense medical centers and Veterans Health Administration health systems — with HIPAA controls today and SOC 2 Type II certification underway, for both federal agencies and commercial health networks.